Patents by Inventor Brian P Dyck

Brian P Dyck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
    Patent number: 7067509
    Abstract: Melanin-concentrating hormone (MCH) receptor antagonists are disclosed having utility for the treatment of MCH receptor-based disorders such as obesity. The compounds of this invention have the following structure: including stereoisomers and pharmaceutically acceptable salts thereof, wherein n, R1, R2, R3, R4, R5, and R6 are as defined herein. Pharmaceutical compositions containing a compound of this invention, as well as methods relating to the use thereof, are also disclosed.
    Type: Grant
    Filed: March 8, 2004
    Date of Patent: June 27, 2006
    Assignee: Neurocrine Biosciences, Inc.
    Inventors: Val Goodfellow, Martin Rowbottom, Brian P Dyck, Junko Tamiya, Mingzhu Zhang, Jonathan Grey, Troy D Vickers, Mehrak Kiankarimi, Warren Wade, Sarah Clough, Joseph Pontillo, Dongpei Wu
  • Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
    Publication number: 20040259931
    Abstract: Melanin-concentrating hormone (MCH) receptor antagonists are disclosed having utility for the treatment of MCH receptor-based disorders such as obesity.
    Type: Application
    Filed: March 8, 2004
    Publication date: December 23, 2004
    Applicant: Neurocrine Biosciences, Inc.
    Inventors: Val Goodfellow, Martin Rowbottom, Brian P. Dyck, Junko Tamiya, Mingzhu Zhang, Jonathan Grey, Troy D. Vickers, Mehrak Kiankarimi, Warren Wade, Sarah Clough Hudson
  • CRF receptor antagonists and methods relating thereto
    Publication number: 20040157851
    Abstract: CRF receptor antagonists are disclosed which have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in a warm-blooded animals, such as stroke.
    Type: Application
    Filed: November 4, 2003
    Publication date: August 12, 2004
    Applicant: Neurocrine Biosciences, Inc.
    Inventors: Mustapha Haddach, Brian P. Dyck, Charles Q. Huang, Jodie Nelson, Zhiqiang Guo, James R. McCarthy
  • CRF receptor antagonists and methods relating thereto
    Publication number: 20040087589
    Abstract: CRF receptor antagonists are disclosed which have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in a warm-blooded animals, such as stroke.
    Type: Application
    Filed: January 8, 2003
    Publication date: May 6, 2004
    Applicant: Neurocrine Biosciences, Inc.
    Inventors: Mustapha Haddach, Brian P. Dyck, Charles Q. Huang, Jodie Nelson, Zhiqiang Guo, James R. McCarthy
  • Ligands of melanocortin receptors and compositions and methods related thereto
    Publication number: 20030158209
    Abstract: Compounds which function as melanocortin receptor ligands and having utility in the treatment of melanocortin receptor-based disorders.
    Type: Application
    Filed: October 9, 2002
    Publication date: August 21, 2003
    Applicant: Neurocrine Biosciences Inc.
    Inventors: Brian P. Dyck, Val Goodfellow, Teresa Phillips, Jessica Parker, Xiaohu Zhang, Chen Chen, Joe Anh Tran, Joseph Pontillo, Fabio C. Tucci
  • CRF receptor antagonists and methods relating thereto
    Patent number: 6531475
    Abstract: CRF receptor antagonists are disclosed which have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in a warm-blooded animals, such as stroke. The CRF receptor antagonists of this invention have the following structure: including stereoisomers and pharmaceutically acceptable salts thereof, wherein n, m, A, B, C, R, R1, R2 and Ar are as defined herein.
    Type: Grant
    Filed: May 18, 2000
    Date of Patent: March 11, 2003
    Assignee: Neurocrine Biosciences, Inc.
    Inventors: Mustapha Haddach, Brian P. Dyck, Charles Q. Huang, Jodie Nelson, Zhiqiang Guo, James R. McCarthy
  • CRF receptor antagonists and methods relating thereto
    Patent number: 6514982
    Abstract: CRF receptor antagonists are disclosed which have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in a warm-blooded animals, such as stroke. The CRF receptor antagonists of this invention have the following structure: including stereoisomers and pharmaceutically acceptable salts thereof, wherein n, m, A, B, C, R, R1, R2 and Ar are as defined herein.
    Type: Grant
    Filed: November 12, 1999
    Date of Patent: February 4, 2003
    Assignee: Neurocrine Biosciences, Inc.
    Inventors: Mustapha Haddach, Brian P. Dyck, Charles Q. Huang, Jodie Nelson, Zhiqiang Guo, James R. McCarthy